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ABSTRACT.
Purpose: To investigate whether the pattern reversal visual evoked potential can 
be useful in the diagnosis and management of macular hole patients.
Methods: The pattern reversal visual evoked potential was measured in 66 pa­
tients with a macular hole and in 43 healthy control subjects. Check sizes of 34’, 
IT  and 10’ were applied.
Results: Results showed that, for the check sizes of 34’, IT  and 10’, eyes with a 
macular hole had significantly prolonged N80 and P100 latencies and a signifi­
cantly reduced P100 amplitude as compared to their fellow eyes. Furthermore, 
for the 10’ check size, the fellow eyes appeared to have a significantly reduced 
PI00 amplitude in comparison with the control eyes, whereas N80 and P100 
latencies of the fellow eyes of the macular hole patients were not prolonged. 
Conclusion: Significant pattern reversal visual evoked potential alterations were 
shown in eyes with macular holes and fellow eyes for small check sizes.
v
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T he pattern reversal visual evoked 
potentials (PRVEP) recorded from 
the occipital midline arise predominantly 
from stimulation of the macula (Kato et 
aî. 1991; Regan 1972). Few reports on the 
outcome of PRVEP stimulation in pa­
tients with a macular hole were pub­
lished, and the authors reported con­
troversial results. All reports agreed that 
in eyes with macular holes PRVEP ampli­
tudes are significantly reduced (Kato et 
ah 1991; Johnson et al. 1987; Bass et al. 
1985; Smith et al. 1990; Wu et al 1992). 
There was no agreement however, on the 
PRVEP (PI00) latency in macular holes. 
Whereas some authors reported a statisti­
cally significant prolongation of (PI00) 
latency in macular holes (Johnson et al. 
1987; Bass et al. 1985; Wu et al. 1992), 
others did not confirm this finding (Kato 
et al. 1991; Smith et al. 1990). Results in 
previous reports were obtained from re­
latively small groups of patients; varying 
from 7 to 32 (Johnson et al. 1987; Smith
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et al. 1990). The check sizes used in for­
mer reports varied from 12’ to 75’ (Kato 
et al. 1991; Johnson et al. 1987). In this 
study we present the outcome of the 
PRVEP in a larger group of patients with 
unilateral or bilateral macular hole 
(N = 66). The data of the macular hole 
eyes were compared to the data of the fel­
low eyes and with a separate group of 
control subjects (N = 43). Goal is to in­
vestigate whether PRVEP can be useful 




The PRVEP registration was part of a 
preoperative protocol for patients with 
unilateral or bilateral macular hole, and 
was measured one day prior to surgical 
intervention. Apart from PRVEP, the pa­
tients were submitted to routine ophthal-
mologic examination, 3 mirror contact 
lens ophthalmoscopy, and a slit beam test.
For comparison of the data we distin­
guished three groups of eyes: I) eyes with 
a macular hole, 2) contralateral eyes of 
patients with unilateral macular hole (fel­
low eyes), and 3) control subjects (separ­
ate group).
in patients with bilateral macular hole 
we only included the data of the eye that 
was indicated to undergo surgery. The 
eyes with macular holes that underwent 
surgery almost all showed stage three ma­
cular holes, according to the Gass criteria 
for macular holes (Gass 1995). Selection 
of contralateral eyes and control eyes for 
analysis was based on the following crite­
ria: 1) visual acuity (VA) ^ 0 .8, 2) no 
known ophthalmologica! disease in the 
examined eye and 3) reliable PRVEP re­
sponse.
To eliminate possible confounding 
caused by age differences (Bemelmans et 
al. 1995) between the macular hole pa­
tients and the control subjects, we re­
stricted the comparison to the age range 
of 55-65 years.
PRVEP registration, analysis and 
labeling of PRVEP components
The active electrode was placed at posi­
tion Oz, 2.5 cm above the inion, the refer­
ring electrode atT3, the mastoid process. 
The grounding was done with an elec- 
trode on the earlobe (Al). Impedance, 
measured at 2 Hz, was kept below five 
kilo Ohms. The ambiant illumination of 
the room was not standardized, though 
kept at mesopic level.
Every eye was optimally refracted for 
the viewing distance. PRVEPs were re­
corded monocularly, using a reversing 
checkerboard pattern generated by a gal- 
vanometer-mirror system (Medilog VPS- 
20). The stimulus consisted of patterns of 
34’, 17’ and 10’ (minutes of arc), reversal
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rate was 2 Hz. Field size was 18 degrees 
for the check size of 34’ and 9 degrees for 
the 17’, and 10’ pattern. The contrast of 
the checks was 80%, mean luminance of 
stimulus was 40 cd/m2. After a 100 dB 
amplification, analog bandpass filtering 
(4th order linear phase filter, bandpass: 
0.16-70 Hz), the evoked response signals 
were digitized (Keithley DAS-16 ADC, 
sampling rate 1000 Hz), 64 successive 
sweeps of 500 ms duration were averaged 
and stored in a computer (Tulip 386 SX 
MSDOS). In addition, a digital low pass 
filter (zero phase) with a cut-off fre­
quency of 40 Hz was applied to the aver­
aged evoked response.
The N 80 latency of the PRVEP com­
plex was measured as the time difference 
between the stimulus reversal and the first 
negative peak (N 80) of the response (see- 
also Figs. 1 and 2a,b for representative 
traces and component labelling). The 
P100 latency of the PRVEP complex was 
measured as the time difference between 
stimulus reversal and the appearance of 
the first (major) positive peak (P100). 
The amplitude of the PRVEP was calcu­
lated as the difference (in pV) between 
the N 80 trough and the P100 peak. This 
amplitude is labelled as the ‘P100 ampli­
tude!
Statistical comparison of PRVEP 
parameters among the groups
Statistical analysis was performed with 
the SAS statistical analysis software 
package (SAS Institute Inc., Cary, NC, 
USA). Exploring the distribution of the 
data in the three groups (macular holes, 
fellow eyes, and control subjects) we 
found that in the macular hole eyes the 
PI00 amplitudes, the N80 and the P100 
latencies were not distributed in a Gaus­
sian manner (Shapiro-Wilk test: p<0.01). 
For this reason the hypothesis test was 
done with non-parametric methods: a 
Wilcoxon-signed-ranks test (paired de­
sign) for comparison of the data from the 
macular hole eyes and their fellow eyes, 
and a Wilcoxon rank-sum test for com­
parison with the (independent) control 
group (Dawson & Trapp 1994; Rossner 
1982; Ederer 1973).
Results
The macular hole group consisted of 66 
patients, 23 male and 43 female. Nine pa­
tients, 3 male and 6 female, had bilateral 
macular holes. Group 2 contained 39 fel­
low eyes of patients with macular holes, 
according to the inclusion criteria, '14 
male and 25 female. Group 3 included 43
Table 1. Means and standard deviations of NS0 and P100 latencies and P 100 amplitude for the 
overall groups.





Macular hole Fellow eye Controls
Mean (SD) N Mean (SD) N Mean (SD) N
N80 latency (ms) 34’ 83.0 (11.5) 58 78.6 (8.2) 38 * *
17’ 89.7 (9.2) 53 82.1 (4.0) 35 82.5 (3.4) 43
10’ 96.1 (11.9) 49 85.7 (5.0) 36 85.2 (3.7) 43
PI00 latency (ms) 34’ 109.4 (8.6) 58 106,4 (7.9) 38 * *
17’ 115.6 (12.9) 53 107,0 (6.9) 35 106.3 (4.6) 43
10’ 124.5 (16.0) 49 111.8 (8.5) 36 110.6 (5.2) 43
P10Q amplitude (jiV) 34’ 5.6 (3.6) 58 8.0 (4.5) 38 * *
17’ 5.6 (3,4) 53 7.6 (4.1) 35 9.4 (4.3) 43
10’ 5.3 (3.9) 49 7.7 (4.8) 36 10.2 (4.0) 43
SD: standard deviation; N: total number; * not examined.
control eyes, 9 male and 34 female. In 
group 1 (macular holes), 5 patients had a 
cataract operation in the affected eye in 
their history, 5 patients underwent a vi­
trectomy before the development of the 
macular hole in the same eye, one patient 
had retinal detachment surgery per­
formed earlier, one patient had an en­
dophthalmitis in the eye with the macular 
hole in his history, one patient had a reti­
nal defect prior to the macular hole, one 
patient had the combination of a macular 
hole and an epiretinal membrane, and the 
remaining 52 patients (52 eyes) idiopa- 
thically developed a macular hole.
Mean VA in the macular hole eyes 
(group 1) was 0.2 (SD -  0.4), mean VA in 
the fellow eyes (group 2) was 0.9 
(SD = 0.1), and 1.0 (SD — 0.1) in the con­
trol eyes (group 3). Mean age of the macu­
lar hole patients was 66 years, ranging 
from 46 to 85 years of age, in the control
group (3) mean age was 58 years, ranging 
from 46 to 82 years of age.
At first, we compared the differences 
within a subject between the macular hole 
eye and the fellow eye. Compared to their 
fellow eyes, eyes with macular hole 
showed significantly (p<0.01) prolonged 
N80 and P100 latencies and a reduced 
P100 amplitude for all three check sizes 
(Tables 1 and 2). When the group of eyes 
with macular hole was compared with a 
separate group of control eyes, both a sig­
nificantly (p<0.01) prolonged N80 and 
P100 latency and a reduced P100 ampli­
tude were found. This was confirmed by 
statistical analysis on a restricted age-in- 
terval (between 55-65 years) in both 
groups, the comparison between eyes 
with macular hole and control eyes show­
ing more pronounced results.
Secondly, for subjects within the age 
range of 55-65 years, we compared the
»
Table 2. Outcome of the hypothesis testing, p < 0.05 was considered significant. Comparison of 
groups 1 vs. 3, and groups 2 vs. 3 was done within the age range of 55-65 years. Table contains 
probabilities of Wilcoxon-signed-ranks-test of eyes in group 1 and 2 (n = 33), and probabilities of 
age-matched two-sample comparisons (Wilcoxon rank-sum test) of macular hole eyes (n = 22) 
and fellow eyes (n = 16) to the separate group of control eyes (n —14).
- Probability scores
Group 1 vs. 3 Group 1 vs. 2 Group 2 vs. 3
PRVEP Check Macular hole eyes Macular hole eyes Fellow eyes
parameter size vs. control eyes vs. fellow eyes vs. control eyes
N 80 latency (ms) 34’ * 0.0011 *
17’ 0.0036 0.0001 ns
10’ 0.0014 0.0001 ns
P100 latency (ms) 34’ * 0.0015 *
17’ 0.0006 0.0001 ns
10* 0.0002 0.0001 ns
P100 amplitude ((xV) 34’ 0.0001 *
17’ 0.0009 0.0001 0.0396
10’ 0.0007 0.0001 ns
ns: not significant; * not examined.
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Fig, 1-
Typical example of pat­
tern visual evoked 
potential in a normal 
subject. Check size: 10’; 
Vertical axis: ± 25 [xV; 
Horizontal axis: 500 ins; 
Arrows indicating N 80 
and P100 peaks in the 
response.
N80 latency: 83 ms;
PI00 latency: 105 ms; 
P100 amplitude: 8,9 |iV.
contralateral eyes (n = 16) with the eyes 
of a separate control group (n = 14). N80 
and P100 latency showed no significant 
difference for check sizes of 17’ and 10’, 
whereas the P 100 amplitude showed a 
significant reduction for the IT check 
size in the fellow eyes (Table 2). There 
was no significant difference of visual 
acuity between the fellow eyes and the 
control group. Typical examples con­
firming this image are shown in the Figs. 1 
and 2.
Discussion
In earlier publications some seemingly 
controversial findings can be found. 
Authors agreed on the finding that 
PRVEP amplitude is significantly re­
duced in patients with macular hole 
(Kato et aL 1991; Johnson et al. 1987; 
Bass et al. 1985; Smith et al. 1990; Wu et 
al. 1992). Our study confirms these re­
sults. No consensus was achieved on the 
PRVEP latency until now. In accordance 
with some authors, we also found signifi­
cantly prolonged N 80 and PI00 latencies 
in eyes with a macular hole compared to 
controls (Johnson et al. 1987; Bass et al.
. 1985), whereas other authors did not find 
significant differences between eyes with 
a macular hole and controls (Smith et al.
1990). Kato et al. (1991), found no dif­
ference in P100 latency between affected 
eye and fellow eye, evoking a steady-state 
PRVEP with check sizes of 50' and 12’. 
We did find, measuring a transient re­
sponse, significantly prolonged N80 and 
P100 latencies between macular holes 
and the fellow eyes (Table 2), in confor­
mity with Wu et al. (1992), who also 
found a prolonged P100 latency in the af­
fected group compared to the fellow eyes.
The difference in results between the 
reports may be due to the pattern sizes 
applied. Small icheck sizes (up to and 
about 15 min of arc) would be expected 
to enhance contributions from the central 
3° of vision, whereas larger check sizes 
would progressively emphasize parafo­
veal contributions (Regan 1989). Most 
earlier reports concluded that the smaller 
check sizes are more likely to detect ab­
normalities produced by small lesions 
such as a macular hole (Kato et al. 1991; 
Johnson et al. 1987; Bass et aL 1985; 
Smith et al. 1990). Their best results were 
obtained with check sizes that vary from 
12’ to 36’. In our study the differences for
both amplitude and latencies were also 
best expressed for the 10’ and the 1.7’ 
check size. For the larger check size (34’) 
the differences were less significant 
(Table 2). Furthermore, the numbers of 
patients studied in other reports were 
smaller, resulting in less reliable outcome.
Several authors described that in fel­
low eyes of eyes with macular holes a 
similar pathogenic process can be found 
which may even result in a contralateral 
macular hole. Percentages vary on the in­
cidence of a macular hole in the fellow eye 
(Trempe et al. 1986; Akiba et al. 1990, 
1992; Aaberg et al. 1970; James & Feman 
1980; Bronstein et al. 1981; Morgan & 
Schatz 1985, 1986, McDonnel et al. 
1982). Comparing the fellow eyes with 
the control eyes, we found a significantly 
reduced amplitude for the 17’ chcck size 
in the fellow eyes (Table 2). No significant 
difference in latency was seen between 
fellow eyes and control eyes. Our results 
suggest that in the process of macular 
hole formation the fellow eye is also in­
volved. The fact that the amplitude is sig­
nificantly reduced in the fellow eyes sug­
gests that in the process of macular hole 
development the amplitude is the first 
parameter to alter. As no significant 
correlation can be found between the VA 
and the P100 amplitude, the VA can not 
be seen as a causal factor for the ampli­
tude reduction in the fellow eyes. What is 
exactly the cause of this amplitude reduc­
tion in these fellow eyes, cannot be con­
cluded from our data. Alteration of the 
N80 and P100 latencies is less pro­
nounced in this preclinical stage and may 
occur later. However, it is not implicated 
that a macular hole in the fellow eye will 
develop.
It is important to realize that pro­
longed latencies and a reduced PRVEP 
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Fig. 2 a. PRVEP of a patient with a macular hole. Check size: 17’; 
N80 and P100 latency are delayed, P100 amplitude considerably 
reduced. Axis definitions as in Fig. 1. N80 latency: 99 ms; P100 
latency: 125 ms; P100 amplitude: 6.2 [iV.
Fig. 2b. PRVEP of the fellow eye of the patient with a macular hole (Fig, 
2a), Check size: 17’; N80 and P100 latency are within the normal range, 
P100 amplitude is reduced. Axis definitions as in Fig. 1.
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pathy or sub clinical alterations of the 
posterior pole of the eye (Johnson et al. 
1987; Lennerstrand 1982), but that 
usually PRVEP examination is indicated 
for pathology of the more central parts of 
the optical visual pathway (Bemelmans et 
al. 1995). Two investigations providing 
additional information about maculo- 
pathy in this context are the focal cone 
ERG and the pattern reversal ERG. The 
focal cone ERG has been described to 
show a reduced amplitude in eyes with 
full-thickness macular holes, as well as in 
fellow eyes that are at risk to develop a 
macular hole in the near future (Birch et 
al. 1988). This investigation provides, 
however, little information about the de­
tailed retinal layers. The pattern reversal 
ERG, most likely providing information 
on the ganglion cell layer, adds more spe­
cified information to the long pathway the 
PRVEP investigation is obtained from 
(Hull & Thompson 1989).
A prospective and longitudinal study 
will be required to investigate whether or 
not the PRVEP has a predictive value in 
the development of macular holes, and 
furthermore whether the PRVEP ampli­
tude or latencies are useful predictors for 
postoperative recovery of VA. If the out­
come would be positive, methods for ma­
cular hole prevention could be developed 
or evaluated.
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